{
    "2020-01-10": [
        [
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)：2019年度净利润预增68.45%-91.13%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "净利润",
                        "预增",
                        "2019年度"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药：2019年净预增68%-91%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "净利润",
                        "预增",
                        "2019年"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德(603259)：去年被高瓴加持48亿，当下还能不能上车？",
                "features": {
                    "keywords": [
                        "药明康德",
                        "高瓴",
                        "加持",
                        "48亿"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "CRO行业迎来黄金发展期，这些企业值得关注",
                "features": {
                    "keywords": [
                        "CRO行业",
                        "黄金发展期",
                        "企业"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}